Context Therapeutics Inc.

NASDAQ:CNTX

Biotechnology

Healthcare
$0.69 +2.93%

+$0.02 today

Market cap
$63.67M
Beta
1.61
P/E (TTM)
-1.5
EPS (TTM)
-$0.42
52W Low $0.56High $3.62

Volume 1.71M

Average 1.16M

Balance Sheet

Inspect the capital base behind the business.

Assets

$68.49M

FY 2025 · Annual

-30.2% YoY

Liabilities

$8.02M

FY 2025 · Annual

+180.4% YoY

Equity

$60.47M

FY 2025 · Annual

-36.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents49.64M35.5M14.45M94.43M66M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets(0)2.36M1.6M3.47M2.36M
Total Current Assets51.26M37.85M16.05M97.9M68.35M
Property, Plant & Equipment (Net)079.54K15.52K230.78K140.07K
Goodwill00000
Intangible Assets00000
Long-term Investments50.39K0000
Tax Assets00000
Other Non-current Assets032.75K000
Total Non-current Assets50.39K112.29K15.52K230.78K140.07K
Total Assets51.31M37.97M16.06M98.13M68.49M
Account Payables1.83M936.33K2.38M1.45M2.53M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities85.53K853.51K661.3K941.7K1.42M
Total Current Liabilities3.03M3.21M4.19M2.75M8.02M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities000112.06K0
Total Liabilities3.03M3.21M4.19M2.86M8.02M
Common Stock15.97K15.97K15.97K89.7K91.88K
Retained Earnings(29.25M)(44.09M)(68.05M)(94.78M)(130.9M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity48.27M34.76M11.87M95.27M60.47M
Total Debt055.08K0219.38K112.06K
Net Debt(49.64M)(35.44M)(14.45M)(94.21M)(65.88M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$54.5M
Other Current$4.0M
Total Current Assets$58.5M
PP&E (Net)$342.3K
Total Non-current Assets$342.3K
Total Assets$58.9M

Analysis

Selected assets total $58.9M for Latest. The largest visible component is Cash & Equivalents at $54.5M, about 92.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipJun 26, 2026
4Statement of changes in beneficial ownershipJun 26, 2026
4Statement of changes in beneficial ownershipJun 26, 2026
4Statement of changes in beneficial ownershipJun 26, 2026
8-KCurrent reportJun 26, 2026

How much cash does CNTX have?

Context Therapeutics Inc. (CNTX) reported $66.00M in cash and equivalents in fiscal 2025.

How much debt does CNTX carry?

Context Therapeutics Inc. (CNTX) reported $112,064.00 of total debt, with net debt of -$65.88M.